Judgment of the Court (Third Chamber), 12 December 2013
Eli Lilly and Company Ltd v Human Genome Sciences Inc
Request for a preliminary ruling from the High Court of Justice (England and Wales), Chancery Division (Patents Court)
Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Article 3 — Conditions for obtaining such a certificate — Concept of a ‘product protected by a basic patent in force’ — Criteria — Wording of the claims of the basic patent — Precision and specificity — Functional definition of an active ingredient — Structural definition of an active ingredient — European Patent Convention
Case C‑493/12
Reports of Cases
published in the electronic Reports of Cases (Court Reports - general)
Links to the texts
|
Curia |
EUR-Lex |
Link |
Judgment
ECLI:EU:C:2013:835 |
|
|
|